Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
BeOne Medicines
AstraZeneca
Fred Hutchinson Cancer Center
Acerta Pharma BV
Mayo Clinic
City of Hope Medical Center
AIDS Malignancy Consortium
Aprea Therapeutics
Oncternal Therapeutics, Inc
Genmab
Stanford University
City of Hope Medical Center
ADC Therapeutics S.A.
PrECOG, LLC.
University of Nebraska
University of Alabama at Birmingham
OHSU Knight Cancer Institute
Asana BioSciences
Atara Biotherapeutics
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Spectrum Pharmaceuticals, Inc
City of Hope Medical Center
Novartis
Mayo Clinic
Fred Hutchinson Cancer Center
Mayo Clinic
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University
Takeda
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Roswell Park Cancer Institute
UNC Lineberger Comprehensive Cancer Center
University of Washington
Rigel Pharmaceuticals
National Cancer Institute (NCI)
Mayo Clinic
National Cancer Institute (NCI)